NCT05754450View on ClinicalTrials.gov

An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II

PHASE3RecruitingINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Leukocyte Adhesion Deficiency

Interventions

DRUG

AVTX-803

L-fucose crystalline powder

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

AUG Therapeutics

All Listed Sponsors

lead

AUG Therapeutics

INDUSTRY

NCT05754450 - An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II | Biotech Hunter | Biotech Hunter